Skip to content

Global nutrition transition and the pandemic of obesity in developing countries

Barry M. Popkin, Linda S. Adair, Shu Wen Ng

Nutrition Reviews · 2012 · 4,672 citationsOpen access

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Popkin, B. M., Adair, L. S., & Ng, S. W. (2012). Global nutrition transition and the pandemic of obesity in developing countries. Nutrition Reviews, 70(1), 3–21. https://doi.org/10.1111/j.1753-4887.2011.00456.x

In text: (Popkin et al., 2012)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

Decades ago, discussion of an impending global pandemic of obesity was thought of as heresy. But in the 1970s, diets began to shift towards increased reliance upon processed foods, increased away-from-home food intake, and increased use of edible oils and sugar-sweetened beverages. Reductions in physical activity and increases in sedentary behavior began to be seen as well. The negative effects of these changes began to be recognized in the early 1990s, primarily in low- and middle-income populations, but they did not become clearly acknowledged until diabetes, hypertension, and obesity began to dominate the globe. Now, rapid increases in the rates of obesity and overweight are widely documented, from urban and rural areas in the poorest countries of sub-Saharan Africa and South Asia to populations in countries with higher income levels. Concurrent rapid shifts in diet and activity are well documented as well. An array of large-scale programmatic and policy measures are being explored in a few countries; however, few countries are engaged in serious efforts to prevent the serious dietary challenges being faced.

  1. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 20192020
  2. Food consumption trends and drivers2010
  3. Pharmaceutical industry sponsorship and research outcome and quality: systematic review2003
  4. Scope and Impact of Financial Conflicts of Interest in Biomedical Research2003
  5. Industry sponsorship and research outcome2017

Metadata from OpenAlex (CC0). Citations are generated from the published record.